BACKGROUND： Cholinergic neuron directly participants in human motion, learning and memory and is a target cell for multiple degenerative diseases of central nervous system. OBJECTIVE： To investigate whether the mito...BACKGROUND： Cholinergic neuron directly participants in human motion, learning and memory and is a target cell for multiple degenerative diseases of central nervous system. OBJECTIVE： To investigate whether the mitotic cell is the radial glial cell expressing choline acetyltransferase （CHAT） in ventricle zone （VZ） of telencephalon and whether cholinergic neuron is derived from radial glial cell in ventricle zone of telencephalon. DESIGN： Observational study. SETTING： Department of Histology and Embryology, Basic Medical College of Jilin University. MATERIALS： Nine healthy Wistar rats included 6 females and 3 male. Male and female rats were mated routinely, and the day when spermatozoa or vaginal plug were found was regarded as embryonic 0 （E0）. Primary monoclonal antibodies ChAT and vimentin were provided respectively by Wuhan Boster Company, and Biogenex Company, USA. METHODS： The experiment was carried out in the Laboratory of Cell Culture and Immunohistochemistry, Department of Histology and Embryology from march 2002 to January 2003. Firstly, fluorescence-activated cell sorting （FACS） was used to confirm the time of generation of cholinergic neuron; secondly, telencephalons of rats at embryonic 14 days （E14） were performed coronary sections, then immunohistochemistry double staining for vimentin （a protein marker of radial neuroglia cell） and ChAT （a protein marker of cholinergic neuron） were used to test whether ChAT was expressed in the radial neuroglia cells. MAIN OUTCOME MEASURES： （1） Fluorescence-activated cell numbers of ChAT in telencephalon; （2） results of immunohistochemistry double staining. RESULTS： It is confirmed using by flow cytometer that embryogenesis time of cholinergic neuron was at E12, and shown the population of cells in VZ of dorsal telencephalon of E14 rat co-expressed vimentin and ChAT through immunohistochemistry double staining. A lot of vimentin-positive cells and ChAT-positive cells respectively were observed in VZ of lateral gan展开更多
BACKGROUND： Acute organophosphate poisoning can cause injuries of multiple visceras; especially,central nervous system injury can increase risk factors of patients with severe acute organophosphate poisoning. An appl...BACKGROUND： Acute organophosphate poisoning can cause injuries of multiple visceras; especially,central nervous system injury can increase risk factors of patients with severe acute organophosphate poisoning. An application of modem image may increase diagnostic rate of brain injury in an earlier period and provide evidences for clinical treatment.OBJECTIVE： To reveal imaging manifestations, pathological characteristics and multi-ways injured mechanism of brain injury due to acute organophosphate poisoning.DESIGN： Contrast observational study.SETTING： Department of Medical Image, the Second Hospital of Hebei Medical University.MATERIALS： The experiment was carried out in the Department of Nerve Molecule Imaging Medicine and Laboratory of Neurology, the Second Hospital of Hebei Medical University from August 2003 to February 2004. A total of 30 healthy cats weighing 2.8 - 3.5 g and of both genders were selected from Animal Experimental Center of Hebei Medical University.METHODS： Thirty healthy cats were randomly divided into control group （n =5） and intoxication group （n=25）. Cats in the control group were subcutaneously injected with 0.3 mL/kg saline at four points; while, cats in the intoxication group were subcutaneously injected with 400 g/L 0.3 mL/kg O,O-dimethyl-S-（methoxycarbonylmethyl） thiophosphate at four points. Two minutes after intoxication, cats received muscular injection with 0.5 mg/kg atropine sulfate, and then, brain tissues were collected from parietal lobe, basal ganglia, hippocampus, cerebellum and brain stem were observed at 3, 6, 24 hours, 3 and 7 days after intoxication respectively under optic microscope and electron microscope and expressions of acetylcholinesterase （AChE）, choline acetyltransferase （ChAT）, glial fibrillary acidic protein （GFAP）,glutamic acid （Glu） and γ-amino butyric acid after immunohistochemical staining.MAIN OUTCOME MEASURES： Results of MRI examinations; histological changes under optic microscope and electron microscope; exp展开更多
OBJECTIVE: To screen the 5' regulatory region of the aldose reductase (AR) gene for genetic variabilities causing changes in protein expression and affecting the promoter function. METHODS: The screenings were car...OBJECTIVE: To screen the 5' regulatory region of the aldose reductase (AR) gene for genetic variabilities causing changes in protein expression and affecting the promoter function. METHODS: The screenings were carried out by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). All SSCP variants were submitted for DNA sequencing and inserted into the plasmid chloromycetin acetyl transferase (CAT) enhancer vector. The constructs were used to transfect Hela cells, and CAT assays were performed to assess promoter activity. Gel mobility shift and footprinting assays were also performed to determine the interaction between the DNA and nuclear proteins. RESULTS: Two polymorphisms, C (-106) T and C (-12) G, were identified in the regulatory region in 123 Chinese control subjects and 145 patients with type 2 diabetes mellitus. The frequencies of genotypes WT/WT, WT/C (-12) G and WT/C (-106) T were not significantly different between the subjects and patients. In the patients with and without retinopathy, frequencies of WT/C (-106) T were 31.5% and 17.5% (P 0.05) respectively. The total frequency of WT/C (-12) G and WT/C (-106) T in patients with retinopathy was 41.8%, significantly higher than that (20.0%) in patients without retinopathy (P展开更多
目的:观察还脑益聪方复方组分早期干预对阿尔茨海默病(Alzhei mer disease,AD)模型β淀粉样前体蛋白(β-amyloid precursor protein,APP)转基因小鼠行为学及脑胆碱能系统的影响。方法:将60只3月龄APP695V717I转基因小鼠随机分为4组:模...目的:观察还脑益聪方复方组分早期干预对阿尔茨海默病(Alzhei mer disease,AD)模型β淀粉样前体蛋白(β-amyloid precursor protein,APP)转基因小鼠行为学及脑胆碱能系统的影响。方法:将60只3月龄APP695V717I转基因小鼠随机分为4组:模型组、大剂量还脑益聪方组[2.80g/(kg.d)]、小剂量还脑益聪方组[1.40g/(kg.d)]及盐酸多奈哌齐阳性对照组[0.65mg/(kg.d)],每组15只。15只遗传背景相同的非转基因C57BL/6J小鼠作为正常对照组。所试药物稀释至相同体积灌胃给药,正常组和模型组给以等体积蒸馏水灌胃,连续灌胃6个月。采用Morris水迷宫实验和避暗实验进行小鼠行为学测试,采用酶联免疫吸附测定法分别检测小鼠大脑皮层和海马组织的乙酰胆碱(acetylcholine,ACh)、乙酰胆碱酯酶(acetylcholinesterase,AChE)含量及胆碱乙酰转移酶(choline acetyltransferase,ChAT)的活性,采用考马斯亮蓝法测定脑组织中蛋白的含量。结果:与正常对照组比较,模型组小鼠学习记忆成绩均显著下降(P<0.05,P<0.01),海马和皮层组织的ACh含量和ChAT活性显著降低,AChE含量显著增加(P<0.01,P<0.05)。与模型组比较,盐酸多奈哌齐组、还脑益聪方组小鼠的学习记忆能力均有明显提高(P<0.05);盐酸多奈哌齐组、还脑益聪方大剂量组小鼠海马ACh含量明显提高(P<0.05),盐酸多奈哌齐组、还脑益聪方组小鼠海马AChE含量显著降低,ChAT活性显著升高(P<0.01,P<0.05);盐酸多奈哌齐组和还脑益聪方两组小鼠皮层ACh含量均明显提高(P<0.05),AChE含量有不同程度的降低,还脑益聪方两组小鼠皮层ChAT活性均明显提高(P<0.05)。结论:还脑益聪方能明显改善APP转基因小鼠的学习记忆能力,其作用机制可能与调控小鼠海马与皮层胆碱能系统相关酶的含量有关。展开更多
基金the Scientific Research Foundation of the Higher Education Institutions, No. 20030183048
文摘BACKGROUND： Cholinergic neuron directly participants in human motion, learning and memory and is a target cell for multiple degenerative diseases of central nervous system. OBJECTIVE： To investigate whether the mitotic cell is the radial glial cell expressing choline acetyltransferase （CHAT） in ventricle zone （VZ） of telencephalon and whether cholinergic neuron is derived from radial glial cell in ventricle zone of telencephalon. DESIGN： Observational study. SETTING： Department of Histology and Embryology, Basic Medical College of Jilin University. MATERIALS： Nine healthy Wistar rats included 6 females and 3 male. Male and female rats were mated routinely, and the day when spermatozoa or vaginal plug were found was regarded as embryonic 0 （E0）. Primary monoclonal antibodies ChAT and vimentin were provided respectively by Wuhan Boster Company, and Biogenex Company, USA. METHODS： The experiment was carried out in the Laboratory of Cell Culture and Immunohistochemistry, Department of Histology and Embryology from march 2002 to January 2003. Firstly, fluorescence-activated cell sorting （FACS） was used to confirm the time of generation of cholinergic neuron; secondly, telencephalons of rats at embryonic 14 days （E14） were performed coronary sections, then immunohistochemistry double staining for vimentin （a protein marker of radial neuroglia cell） and ChAT （a protein marker of cholinergic neuron） were used to test whether ChAT was expressed in the radial neuroglia cells. MAIN OUTCOME MEASURES： （1） Fluorescence-activated cell numbers of ChAT in telencephalon; （2） results of immunohistochemistry double staining. RESULTS： It is confirmed using by flow cytometer that embryogenesis time of cholinergic neuron was at E12, and shown the population of cells in VZ of dorsal telencephalon of E14 rat co-expressed vimentin and ChAT through immunohistochemistry double staining. A lot of vimentin-positive cells and ChAT-positive cells respectively were observed in VZ of lateral gan
文摘BACKGROUND： Acute organophosphate poisoning can cause injuries of multiple visceras; especially,central nervous system injury can increase risk factors of patients with severe acute organophosphate poisoning. An application of modem image may increase diagnostic rate of brain injury in an earlier period and provide evidences for clinical treatment.OBJECTIVE： To reveal imaging manifestations, pathological characteristics and multi-ways injured mechanism of brain injury due to acute organophosphate poisoning.DESIGN： Contrast observational study.SETTING： Department of Medical Image, the Second Hospital of Hebei Medical University.MATERIALS： The experiment was carried out in the Department of Nerve Molecule Imaging Medicine and Laboratory of Neurology, the Second Hospital of Hebei Medical University from August 2003 to February 2004. A total of 30 healthy cats weighing 2.8 - 3.5 g and of both genders were selected from Animal Experimental Center of Hebei Medical University.METHODS： Thirty healthy cats were randomly divided into control group （n =5） and intoxication group （n=25）. Cats in the control group were subcutaneously injected with 0.3 mL/kg saline at four points; while, cats in the intoxication group were subcutaneously injected with 400 g/L 0.3 mL/kg O,O-dimethyl-S-（methoxycarbonylmethyl） thiophosphate at four points. Two minutes after intoxication, cats received muscular injection with 0.5 mg/kg atropine sulfate, and then, brain tissues were collected from parietal lobe, basal ganglia, hippocampus, cerebellum and brain stem were observed at 3, 6, 24 hours, 3 and 7 days after intoxication respectively under optic microscope and electron microscope and expressions of acetylcholinesterase （AChE）, choline acetyltransferase （ChAT）, glial fibrillary acidic protein （GFAP）,glutamic acid （Glu） and γ-amino butyric acid after immunohistochemical staining.MAIN OUTCOME MEASURES： Results of MRI examinations; histological changes under optic microscope and electron microscope; exp
文摘OBJECTIVE: To screen the 5' regulatory region of the aldose reductase (AR) gene for genetic variabilities causing changes in protein expression and affecting the promoter function. METHODS: The screenings were carried out by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). All SSCP variants were submitted for DNA sequencing and inserted into the plasmid chloromycetin acetyl transferase (CAT) enhancer vector. The constructs were used to transfect Hela cells, and CAT assays were performed to assess promoter activity. Gel mobility shift and footprinting assays were also performed to determine the interaction between the DNA and nuclear proteins. RESULTS: Two polymorphisms, C (-106) T and C (-12) G, were identified in the regulatory region in 123 Chinese control subjects and 145 patients with type 2 diabetes mellitus. The frequencies of genotypes WT/WT, WT/C (-12) G and WT/C (-106) T were not significantly different between the subjects and patients. In the patients with and without retinopathy, frequencies of WT/C (-106) T were 31.5% and 17.5% (P 0.05) respectively. The total frequency of WT/C (-12) G and WT/C (-106) T in patients with retinopathy was 41.8%, significantly higher than that (20.0%) in patients without retinopathy (P
